“Real-World Clinical Outcomes of Ujvira® (Trastuzumab Emtansine Biosimilar) in HER2-Positive Breast Cancer: A Retrospective Observational Study in Indian Patients” (2025) Journal of Cancer Research Updates, 14, pp. 114–120. doi:10.30683/1929-2279.2025.14.13.